[1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[4-(1,1-dideuterio-2-methylpropyl)-2-(4-phenylphenyl)-6-[3-(trideuteriomethyl)phenyl]phenyl]benzimidazol-2-ylidene]platinum

C72H56BN5OPt — CID 177090462

IUPAC[1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[4-(1,1-dideuterio-2-methylpropyl)-2-(4-phenylphenyl)-6-[3-(trideuteriomethyl)phenyl]phenyl]benzimidazol-2-ylidene]platinum
SMILES[2H]C([2H])([2H])c1cccc(-c2cc(C([2H])([2H])C(C)C)cc(-c3ccc(-c4ccccc4)cc3)c2-n2c(=[Pt])n(-c3cccc(Oc4nc(N5B6c7ccccc7-c7ccccc7N6c6ccccc65)cc(C([2H])([2H])[2H])c4-c4ccccc4)c3)c3ccccc32)c1
InChIInChI=1S/C72H56BN5O.Pt/c1-48(2)41-51-44-61(54-39-37-53(38-40-54)52-22-7-5-8-23-52)71(62(45-51)56-26-19-21-49(3)42-56)76-47-75(65-33-15-16-34-66(65)76)57-27-20-28-58(46-57)79-72-70(55-24-9-6-10-25-55)50(4)43-69(74-72)78-68-36-18-17-35-67(68)77-64-32-14-12-30-60(64)59-29-11-13-31-63(59)73(77)78;/h5-40,42-46,48H,41H2,1-4H3;/i3D3,4D3,41D2;
InChIKeyXBCIFCBIOSMQIO-UGPDOMHSSA-N
MW1221.21 g/mol
LogP17.84
Rot. Bonds13

About [1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[4-(1,1-dideuterio-2-methylpropyl)-2-(4-phenylphenyl)-6-[3-(trideuteriomethyl)phenyl]phenyl]benzimidazol-2-ylidene]platinum

[1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[4-(1,1-dideuterio-2-methylpropyl)-2-(4-phenylphenyl)-6-[3-(trideuteriomethyl)phenyl]phenyl]benzimidazol-2-ylidene]platinum (PubChem CID 177090462) has the molecular formula C72H56BN5OPt and a molecular weight of 1221.21 g/mol. Its IUPAC name is [1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[4-(1,1-dideuterio-2-methylpropyl)-2-(4-phenylphenyl)-6-[3-(trideuteriomethyl)phenyl]phenyl]benzimidazol-2-ylidene]platinum.

Molecular Properties

Compound Name[1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[4-(1,1-dideuterio-2-methylpropyl)-2-(4-phenylphenyl)-6-[3-(trideuteriomethyl)phenyl]phenyl]benzimidazol-2-ylidene]platinum
PubChem CID177090462
Molecular FormulaC72H56BN5OPt
Molecular Weight1221.21 g/mol
Exact Mass1220.47
IUPAC Name[1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[4-(1,1-dideuterio-2-methylpropyl)-2-(4-phenylphenyl)-6-[3-(trideuteriomethyl)phenyl]phenyl]benzimidazol-2-ylidene]platinum
SMILES[2H]C([2H])([2H])c1cccc(-c2cc(C([2H])([2H])C(C)C)cc(-c3ccc(-c4ccccc4)cc3)c2-n2c(=[Pt])n(-c3cccc(Oc4nc(N5B6c7ccccc7-c7ccccc7N6c6ccccc65)cc(C([2H])([2H])[2H])c4-c4ccccc4)c3)c3ccccc32)c1
InChIInChI=1S/C72H56BN5O.Pt/c1-48(2)41-51-44-61(54-39-37-53(38-40-54)52-22-7-5-8-23-52)71(62(45-51)56-26-19-21-49(3)42-56)76-47-75(65-33-15-16-34-66(65)76)57-27-20-28-58(46-57)79-72-70(55-24-9-6-10-25-55)50(4)43-69(74-72)78-68-36-18-17-35-67(68)77-64-32-14-12-30-60(64)59-29-11-13-31-63(59)73(77)78;/h5-40,42-46,48H,41H2,1-4H3;/i3D3,4D3,41D2;
InChIKeyXBCIFCBIOSMQIO-UGPDOMHSSA-N
XLogP17.84
TPSA38.46 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds13
Heavy Atoms80
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001221.21
LogP ≤ 517.84
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze [1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[4-(1,1-dideuterio-2-methylpropyl)-2-(4-phenylphenyl)-6-[3-(trideuteriomethyl)phenyl]phenyl]benzimidazol-2-ylidene]platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[4-(1,1-dideuterio-2-methylpropyl)-2-(4-phenylphenyl)-6-[3-(trideuteriomethyl)phenyl]phenyl]benzimidazol-2-ylidene]platinum?
The IUPAC name of [1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[4-(1,1-dideuterio-2-methylpropyl)-2-(4-phenylphenyl)-6-[3-(trideuteriomethyl)phenyl]phenyl]benzimidazol-2-ylidene]platinum (CID 177090462) is [1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[4-(1,1-dideuterio-2-methylpropyl)-2-(4-phenylphenyl)-6-[3-(trideuteriomethyl)phenyl]phenyl]benzimidazol-2-ylidene]platinum.
What is the SMILES notation for [1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[4-(1,1-dideuterio-2-methylpropyl)-2-(4-phenylphenyl)-6-[3-(trideuteriomethyl)phenyl]phenyl]benzimidazol-2-ylidene]platinum?
The canonical SMILES for [1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[4-(1,1-dideuterio-2-methylpropyl)-2-(4-phenylphenyl)-6-[3-(trideuteriomethyl)phenyl]phenyl]benzimidazol-2-ylidene]platinum is [2H]C([2H])([2H])c1cccc(-c2cc(C([2H])([2H])C(C)C)cc(-c3ccc(-c4ccccc4)cc3)c2-n2c(=[Pt])n(-c3cccc(Oc4nc(N5B6c7ccccc7-c7ccccc7N6c6ccccc65)cc(C([2H])([2H])[2H])c4-c4ccccc4)c3)c3ccccc32)c1.
What is the InChIKey of [1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[4-(1,1-dideuterio-2-methylpropyl)-2-(4-phenylphenyl)-6-[3-(trideuteriomethyl)phenyl]phenyl]benzimidazol-2-ylidene]platinum?
The InChIKey is XBCIFCBIOSMQIO-UGPDOMHSSA-N. The full InChI is InChI=1S/C72H56BN5O.Pt/c1-48(2)41-51-44-61(54-39-37-53(38-40-54)52-22-7-5-8-23-52)71(62(45-51)56-26-19-21-49(3)42-56)76-47-75(65-33-15-16-34-66(65)76)57-27-20-28-58(46-57)79-72-70(55-24-9-6-10-25-55)50(4)43-69(74-72)78-68-36-18-17-35-67(68)77-64-32-14-12-30-60(64)59-29-11-13-31-63(59)73(77)78;/h5-40,42-46,48H,41H2,1-4H3;/i3D3,4D3,41D2;.
What are the key properties of [1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[4-(1,1-dideuterio-2-methylpropyl)-2-(4-phenylphenyl)-6-[3-(trideuteriomethyl)phenyl]phenyl]benzimidazol-2-ylidene]platinum?
[1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[4-(1,1-dideuterio-2-methylpropyl)-2-(4-phenylphenyl)-6-[3-(trideuteriomethyl)phenyl]phenyl]benzimidazol-2-ylidene]platinum has a molecular weight of 1221.21 g/mol, XLogP of 17.84, 13 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[4-(1,1-dideuterio-2-methylpropyl)-2-(4-phenylphenyl)-6-[3-(trideuteriomethyl)phenyl]phenyl]benzimidazol-2-ylidene]platinum is sourced from PubChem (CID 177090462), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).